Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

Background Heterogeneous evidence exists on the effect of coronavirus disease 2019
(COVID‐19) on the clinical outcomes of patients with cancer. Methods A systematic review …

Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

Background All countries are facing decisions about which population groups to prioritize for
access to COVID-19 vaccination after the first vaccine products have been licensed, at which …

Abstract Information regarding the novel coronavirus disease (COVID‐19) in pediatric
oncology is limited. We conducted a systematic review of the available published literature …

Objective The aim of this study was to analyze the available knowledge about the potential
association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) …

Background Cancer has been suggested as a risk factor for severe outcome of SARS-CoV-2
infection. In this population-based study we aimed to identify factors associated with higher …

The efficacy of SARS-CoV-2 vaccination in patients with hematological malignancies (HM)
appears limited due to disease and treatment-associated immune impairment. We …

Risk perception and consequently engagement in behaviors to avoid illness often do not
match actual risk of infection, morbidity, and mortality. Unrealistic optimism occurs when …